Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Advances in Brief

Germ Line Mutation at BRCA1 Affects the Histoprognostic Grade in Hereditary Breast Cancer

François Eisinger, Dominique Stoppa-Lyonnet, Michel Longy, Fabienne Kerangueven, Tetsuro Noguchi, Christiane Bailly, Anne Vincent-Salomon, Jocelyn Jacquemier, Daniel Birnbaum and Hagay Sobol
François Eisinger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominique Stoppa-Lyonnet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Longy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabienne Kerangueven
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsuro Noguchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christiane Bailly
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Vincent-Salomon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jocelyn Jacquemier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Birnbaum
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hagay Sobol
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published February 1996
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Histoprognostic grade is a determinant parameter to select the initial therapeutic strategy in breast cancer. Our aim was to analyze the grade repartition in BRCA1-associated breast cancer (BC) and to explore the possible connections between grade and the BRCA1 gene function. We first compared 27 BRCA1-associated BCs from 14 families with 4461 cases from an administrative district registry and 242 cases from a hospital-based registry, matching for grade and constitutive elements, and then considered their repartition in families.

We observed a prevalence of grade 3 (P < 0.0001) in BRCA1-associated BC. This was attributed mainly to nuclear polymorphism (P < 0.0001), mitotic activity (P < 0.0001), and tubular differentiation (P = 0.0004), implying that BRCA1-associated BCs are highly proliferating tumors. Moreover, it is suggested that grade segregates as a genetic trait within families (P = 0.0015), and this was attributed to the mitotic index segregation only (P = 0.0005). Therefore grade, through its components, could be interpreted as the morphological translation of the BRCA1 germ line mutation. Thus, a genotype-phenotype correlation may exist between the type of mutation and the aggressiveness of the disease.

These findings are bound to have an important impact in the care management of hereditary breast cancer at the individual and at the familial level and in the comprehensive approach of breast cancer development.

Footnotes

  • ↵1 This work was supported by Paoli-Calmettes Institute, INSERM, and grants from La Ligue Nationale Contre le Cancer (the National Office and the district committees of Alpes de Haute Provence, Bouches du Rhône, Corse du Sud, Haute Corse, Var), Caisse Nationale d'Assurance Maladie, CAMPLP, FEGEFLUC, Association pour la Recherche sur le Cancer, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupement de Recherche et d'Etude sur les Génomes.

  • ↵2 To whom requests for reprints should be addressed. Phone: (33) 91-22-35-40; Fax: (33) 91-22-35-04.

  • Received October 17, 1995.
  • Accepted December 12, 1995.
  • ©1996 American Association for Cancer Research.
PreviousNext
Back to top
February 1996
Volume 56, Issue 3
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Germ Line Mutation at BRCA1 Affects the Histoprognostic Grade in Hereditary Breast Cancer
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Germ Line Mutation at BRCA1 Affects the Histoprognostic Grade in Hereditary Breast Cancer
François Eisinger, Dominique Stoppa-Lyonnet, Michel Longy, Fabienne Kerangueven, Tetsuro Noguchi, Christiane Bailly, Anne Vincent-Salomon, Jocelyn Jacquemier, Daniel Birnbaum and Hagay Sobol
Cancer Res February 1 1996 (56) (3) 471-474;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Germ Line Mutation at BRCA1 Affects the Histoprognostic Grade in Hereditary Breast Cancer
François Eisinger, Dominique Stoppa-Lyonnet, Michel Longy, Fabienne Kerangueven, Tetsuro Noguchi, Christiane Bailly, Anne Vincent-Salomon, Jocelyn Jacquemier, Daniel Birnbaum and Hagay Sobol
Cancer Res February 1 1996 (56) (3) 471-474;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Advances in Brief

  • Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
  • Recombinant Listeria Vaccines Containing PEST Sequences Are Potent Immune Adjuvants for the Tumor-Associated Antigen Human Papillomavirus-16 E7
  • 2-Arachidonoylglycerol
Show more Advances in Brief

Articles

  • BCL-2 Gene Family and the Regulation of Programmed Cell Death
  • Identification and Characterization of Collaborating Oncogenes in Compound Mutant Mice
  • Introduction of H. Robert Horvitz
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement